An Evolved Adeno-associated Viral Variant Enhances Gene Delivery and Gene Targeting in Neural Stem Cells
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Gene delivery to, and gene targeting in, stem cells would be a highly enabling technology for basic science and biomedical application. Adeno-associated viral (AAV) vectors have demonstrated the capacity for efficient delivery to numerous cells, but their application to stem cells has been limited by low transduction efficiency. Due to their considerable advantages, however, engineering AAV delivery systems to enhance gene delivery to stem cells may have an impact in stem cell biology and therapy. Therefore, using several diverse AAV capsid libraries-including randomly mutagenized, DNA shuffled, and random peptide insertion variants-we applied directed evolution to create a "designer" AAV vector with enhanced delivery efficiency for neural stem cells (NSCs). A novel AAV variant, carrying an insertion of a selected peptide sequence on the surface of the threefold spike within the heparin-binding site, emerged from this evolution. Importantly, this evolved AAV variant mediated efficient gene delivery to rat, mouse, and human NSCs, as well as efficient gene targeting within adult NSCs, and it is thus promising for applications ranging from basic stem cell biology to clinical translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
Ferrari, F. K., Samulski, T., Shenk, T., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3227-3234.1996 · Cited by 761
Directed evolution of adeno-associated virus yields enhanced gene delivery vectors
Maheshri, N., Koerber, J. T., Kaspar, B. K., & Schaffer, D. V. (2006) · Nature Biotechnology · doi:10.1038/nbt1182 · Cited by 538
Self-citationPI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation
Peltier, J., O'Neill, A., & Schaffer, D. V. (2007) · Developmental Neurobiology · doi:10.1002/dneu.20506 · Cited by 443
Self-citationBennicelli, J., Wright, J. F., Komaromy, A., Jacobs, J. B., Hauck, B., Zelenaia, O., Mingozzi, F., Hui, D., Chung, D., Rex, T. S., et al. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300389 · Cited by 267
Klimczak, R. R., Koerber, J. T., Dalkara, D., Flannery, J. G., & Schaffer, D. V. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007467 · Cited by 210
Self-citationMolecular evolution of adeno-associated virus for enhanced glial gene delivery
Koerber, J. T., Klimczak, R., Jang, J.-H., Dalkara, D., Flannery, J. G., & Schaffer, D. V. (2009) · Molecular Therapy · doi:10.1038/mt.2009.184 · Cited by 181
Self-citationDNA Shuffling of Adeno-associated Virus Yields Functionally Diverse Viral Progeny
Koerber, J. T., Jang, J.-H., & Schaffer, D. V. (2008) · Molecular Therapy · doi:10.1038/mt.2008.167 · Cited by 181
Self-citationGene targeting with viral vectors
Hendrie, P. C., & Russell, D. W. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.006 · Cited by 126 · cited 1×
“(b) Directed evolution of novel AAV vectors for enhanced NSC infection: (1) plasmid libraries were generated by DNA shuffling, peptide insertion, and error prone PCR [error prone (EP)], (2) viral libraries were packaged, (3) NSCs were infected with libraries, followed by adenovirus addition, (4) the”
Method
Research works printed but not linked: 39
- Yates, 2006, Progress and prospects: gene transfer into embryonic stem cells, Gene Ther, 13, 1431, 10.1038/sj.gt.3302854 · DOI
- Madeira, 2010, Nonviral gene delivery to mesenchymal stem cells using cationic liposomes for gene and cell therapy, J Biomed Biotechnol, 2010, 735349, 10.1155/2010/735349 · DOI
- Jo, 2008, Non-viral gene transfection technologies for genetic engineering of stem cells, Eur J Pharm Biopharm, 68, 90, 10.1016/j.ejpb.2007.04.021 · DOI
- Singer, 2006, Rapid generation of knockdown transgenic mice by silencing lentiviral vectors, Nat Protoc, 1, 286, 10.1038/nprot.2006.44 · doi:10.1038/nprot.2006.44
- Marumoto, 2009, Development of a novel mouse glioma model using lentiviral vectors, Nat Med, 15, 110, 10.1038/nm.1863 · DOI · Paper page
- Fan, 2002, Transient disruption of autocrine TGF-beta signaling leads to enhanced survival and proliferation potential in single primitive human hemopoietic progenitor cells, J Immunol, 168, 755, 10.4049/jimmunol.168.2.755 · DOI · Paper page
- Silva, 2008, Promotion of reprogramming to ground state pluripotency by signal inhibition, PLoS Biol, 6, e253, 10.1371/journal.pbio.0060253 · DOI · Paper page
- Hester, 2009, Two factor reprogramming of human neural stem cells into pluripotency, PLoS ONE, 4, e7044, 10.1371/journal.pone.0007044 · DOI · Paper page
- Gropp, 2003, Stable genetic modification of human embryonic stem cells by lentiviral vectors, Mol Ther, 7, 281, 10.1016/S1525-0016(02)00047-3 · DOI · Paper page
- Suzuki, 2008, Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors, Proc Natl Acad Sci USA, 105, 13781, 10.1073/pnas.0806976105 · DOI
- Conrad, 2007, Genetically engineered stem cells for therapeutic gene delivery, Curr Gene Ther, 7, 249, 10.2174/156652307781369119 · DOI
- Lim, 2010, Specific insertions of zinc finger domains into Gag-Pol yield engineered retroviral vectors with selective integration properties, Proc Natl Acad Sci USA, 107, 12475, 10.1073/pnas.1001402107 · DOI
- Urnov, 2005, Highly efficient endogenous human gene correction using designed zinc-finger nucleases, Nature, 435, 646, 10.1038/nature03556 · DOI · Paper page
- Verma, 2005, Gene therapy: twenty-first century medicine, Annu Rev Biochem, 74, 711, 10.1146/annurev.biochem.74.050304.091637 · DOI · Paper page
- Kaplitt, 1994, Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain, Nat Genet, 8, 148, 10.1038/ng1094-148 · DOI · Paper page
- Flannery, 1997, Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus, Proc Natl Acad Sci USA, 94, 6916, 10.1073/pnas.94.13.6916 · DOI · Paper page
- Russell, 1998, Human gene targeting by viral vectors, Nat Genet, 18, 325, 10.1038/ng0498-325 · DOI · Paper page
- Chamberlain, 2004, Gene targeting in stem cells from individuals with osteogenesis imperfecta, Science, 303, 1198, 10.1126/science.1088757 · DOI · Paper page
- Rogers, 2008, Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer, J Clin Invest, 118, 1571, 10.1172/JCI34773 · DOI · Paper page
- Smith-Arica, 2003, Infection efficiency of human and mouse embryonic stem cells using adenoviral and adeno-associated viral vectors, Cloning Stem Cells, 5, 51, 10.1089/153623003321512166 · DOI · Paper page
- Hughes, 2002, Viral-mediated gene transfer to mouse primary neural progenitor cells, Mol Ther, 5, 16, 10.1006/mthe.2001.0512 · DOI · Paper page
- Temple, 2001, The development of neural stem cells, Nature, 414, 112, 10.1038/35102174 · DOI · Paper page
- Lai, 2003, Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo, Nat Neurosci, 6, 21, 10.1038/nn983 · DOI · Paper page
- Excoffon, 2009, Directed evolution of adeno-associated virus to an infectious respiratory virus, Proc Natl Acad Sci USA, 106, 3865, 10.1073/pnas.0813365106 · DOI · Paper page
- Müller, 2003, Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors, Nat Biotechnol, 21, 1040, 10.1038/nbt856 · DOI · Paper page
- Opie, 2003, Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding, J Virol, 77, 6995, 10.1128/JVI.77.12.6995-7006.2003 · DOI · Paper page
- Hansen, 2000, Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts, J Virol, 74, 992, 10.1128/JVI.74.2.992-996.2000 · DOI · Paper page
- Kim, 2009, Direct reprogramming of human neural stem cells by OCT4, Nature, 461, 643, 10.1038/nature08436 · DOI · Paper page
- Kim, 2009, Oct4-induced pluripotency in adult neural stem cells, Cell, 136, 411, 10.1016/j.cell.2009.01.023 · DOI · Paper page
- Palmer, 1999, Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS, J Neurosci, 19, 8487, 10.1523/JNEUROSCI.19-19-08487.1999 · DOI · Paper page
- Kim, 2006, Human neurospheres derived from the fetal central nervous system are regionally and temporally specified but are not committed, Exp Neurol, 199, 222, 10.1016/j.expneurol.2006.03.015 · DOI
- Perabo, 2003, In vitro selection of viral vectors with modified tropism: the adeno-associated virus display, Mol Ther, 8, 151, 10.1016/S1525-0016(03)00123-0 · DOI · Paper page
- Stemmer, 1994, Rapid evolution of a protein in vitro by DNA shuffling, Nature, 370, 389, 10.1038/370389a0 · DOI · Paper page
- Zhao, 1997, Optimization of DNA shuffling for high fidelity recombination, Nucleic Acids Res, 25, 1307, 10.1093/nar/25.6.1307 · DOI · Paper page
- Batard, 2001, Transfer of high copy number plasmid into mammalian cells by calcium phosphate transfection, Gene, 270, 61, 10.1016/S0378-1119(01)00467-X · DOI · Paper page
- Koerber, 2006, Construction of diverse adeno-associated viral libraries for directed evolution of enhanced gene delivery vehicles, Nat Protoc, 1, 701, 10.1038/nprot.2006.93 · DOI
- Lois, 2002, Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors, Science, 295, 868, 10.1126/science.1067081 · DOI · Paper page
- Yu, 2006, Selection of novel vesicular stomatitis virus glycoprotein variants from a peptide insertion library for enhanced purification of retroviral and lentiviral vectors, J Virol, 80, 3285, 10.1128/JVI.80.7.3285-3292.2006 · DOI · Paper page
- Leonard, 2008, HIV evades RNA interference directed at TAR by an indirect compensatory mechanism, Cell Host Microbe, 4, 484, 10.1016/j.chom.2008.09.008 · DOI
Cited by
A Designer AAV Variant Permits Efficient Retrograde Access to Projection Neurons
Tervo, D. G. R., Hwang, B.-Y., Viswanathan, S., Gaj, T., Lavzin, M., Ritola, K. D., Lindo, S., Michael, S., Kuleshova, E., Ojala, D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.021 · Cited by 1,179
Self-citationEngineering adeno-associated viruses for clinical gene therapy
Kotterman, M. A., & Schaffer, D. V. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3742 · Cited by 761
Self-citationThe AAV Vector Toolkit: Poised at the Clinical Crossroads
Asokan, A., Schaffer, D. V., & Jude Samulski, R. (2012) · Molecular Therapy · doi:10.1038/mt.2011.287 · Cited by 465
Self-citationViral Vectors for Gene Therapy: Translational and Clinical Outlook
Kotterman, M. A., Chalberg, T. W., & Schaffer, D. V. (2015) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-104938 · Cited by 424
Self-citationTargeting protein and peptide therapeutics to the heart via tannic acid modification
Shin, M., Lee, H.-A., Lee, M., Shin, Y., Song, J.-J., Kang, S.-W., Nam, D.-H., Jeon, E. J., Cho, M., Do, M., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0227-9 · Cited by 324
Self-citation
Metadata
- Authors
- Jang, J.-H., Koerber, J. T., Kim, J.-S., Asuri, P., Vazin, T., Bartel, M., Keung, A., Kwon, I., Park, K. I., & Schaffer, D. V.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 19
- Issue
- 4
- Pages
- 667-675
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2103037531
- Cited by
- 101
- References
- 9
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 2016 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.